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Scientific objectives
Some important aspects in evidence-based medicine
have not been included in basic and applied research.
The current level of examination of the cardiovascular
system requires new analytical approaches for the pre-
vention of cardiovascular diseases, insults and infarc-
tions in people of different age, and diminishing of
disability and mortality of vascular critical states.
Technological approaches
The technology of vascular screening enables not only
to make accurate diagnoses but also to treat efficiently
that reduces financial burden of a patient and his rela-
tives. The medical technology will be useful in prophy-
lactic and preventive medicine of the world for the
health improvement of CVD patients.
Results interpretation
Regular vascular screening enables to perform diagnos-
tics of microcirculatory disorders, to control efficiency
of the therapy almost for every patient non-invasively
(psychoneurological, therapeutic, angiological, endocri-
nological, and cancer neovascularization profiles for the
assessment of congenital and acquired vascular anoma-
lies) and during prophylactic exanimations of healthy
people who are under influence of external factors,
resuscitation departments, insurance medicine and
sports medicine.
Outlook and expert recommendations
The approaches to the analytical estimation of the vas-
cular pipeline on macro- and microlevels allow newly
considered problems in the blood supply for organs and
systems in the human organism. It enables to estimate
the possibility of sanogenic reconstructions in the vascu-
lar bed on local, regional, and systemic levels, and the
adequacy of such alterations according to the necessities
of the ill organism.
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